Martin Filipits

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Topics

Early Breast Cancer

Mitochondrial Dna

Circulating Tumor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Targeted oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Filipits, Verena Kainz, Viktor Sebek, Herwig Zach, null On Behalf Of The Liquid Biopsy Collaborative Study Group
Epidermal Growth Factor Receptor T790M Mutation Testing in Non-Small Cell Lung Cancer: An International Collaborative Study to Assess Molecular EGFR T790M Testing in Liquid Biopsy. Cancers 15 (13) (2023)
Christian F Singer, null null, Frederik Holst, Stefan Steurer, Eike C Burandt, Sigurd F Lax, Raimund Jakesz, Margaretha Rudas, Herbert Stöger, Richard Greil, null null, Guido Sauter, Martin Filipits, null null, Ronald Simon, Michael Gnant, null null
Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (18) (2022)
Anna Buder, Ellen Heitzer, Julie Waldispühl-Geigl, Sabrina Weber, Tina Moser, Maximilian Johannes Hochmair, Klaus Hackner, Peter Errhalt, Ulrike Setinek, Martin Filipits
Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma Patients. Biomolecules 11 (5) (2021)
Qing Zhou, Simon Peter Gampenrieder, Sophie Frantal, Gabriel Rinnerthaler, Christian F Singer, Daniel Egle, Georg Pfeiler, Rupert Bartsch, Viktor Wette, Angelika Pichler, Edgar Petru, Peter C Dubsky, Zsuzsanna Bago-Horvath, Christian Fesl, Margaretha Rudas, Anders Ståhlberg, Ricarda Graf, Sabrina Weber, Nadia Dandachi, Martin Filipits, Michael Gnant, Marija Balić, Ellen Heitzer
Persistence of ctDNA in breast cancer patients during neoadjuvant treatment is a significant predictor of poor tumour response. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Sandra Pflügler, Jasmin Svinka, Irene Scharf, Ilija Crncec, Martin Filipits, Pornpimol Charoentong, Markus Tschurtschenthaler, Lukas Kenner, Monira Awad, Judith Stift, Marina Schernthanner, Romana Bischl, Dietmar Herndler-Brandstetter, Elisabeth Glitzner, Herwig P Moll, Emilio Casanova, Gerald Timelthaler, Maria Sibilia, Michael Gnant, Sigurd Lax, Josef Thaler, Mathias Müller, Birgit Strobl, Thomas Mohr, Arthur Kaser, Zlatko Trajanoski, Gerwin Heller, Robert Eferl
IDO1+ Paneth cells promote immune escape of colorectal cancer. Communications biology 3 (1) (2020)
Anna Buder, Maximilian J Hochmair, Martin Filipits
The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with Osimertinib. Targeted oncology 16 (1) (2020)
Ivana Sestak, Martin Filipits, Richard Buus, Margaretha Rudas, Marija Balić, Michael Knauer, Ralf Kronenwett, Florian Fitzal, Jack M Cuzick, Michael Gnant, Richard Greil, Mitch Dowsett, Peter Dubsky
Prognostic Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative Invasive Lobular Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (17) (2020)
Alexandra Posch, Sarah Hofer-Zeni, Eckhard Klieser, Florian Primavesi, Elisabeth Naderlinger, Anita Brandstetter, Martin Filipits, Romana Urbas, Stefan Swiercynski, Tarkan Jäger, Paul Winkelmann, Tobias Kiesslich, Changquan Ling, Daniel Neureiter, Stefan Stättner, Klaus Holzmann
Hot Spot TERT Promoter Mutations Are Rare in Sporadic Pancreatic Neuroendocrine Neoplasms and Associated with Telomere Length and Epigenetic Expression Patterns. Cancers 12 (6) (2020)
Zsuzsanna Bago-Horvath, Margaretha Rudas, Christian F Singer, Richard Greil, Marija Balić, Sigurd F Lax, Werner Kwasny, Wolfgang Hulla, Michael Gnant, Martin Filipits
Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (21) (2020)
Robert Pirker, Martin Filipits
From crizotinib to lorlatinib: continuous improvement in precision treatment of ALK-positive non-small cell lung cancer. ESMO open 4 (5) (2019)